Adalimumab-atto Subcutaneous and Empagliflozin and linagliptin

• Generic Name: adalimumab
• Dosage Forms: n.a.
• Other Brand Names: Humira, Humira Pen, Humira Pen Crohns/UlcerColit/HidraSuppur, Humira Pen Psoriasis/Uveitis Starter Package, Humira Pediatric, Humira Pediatric Crohn's Disease Starter Pack, Humira Pre-Filled Syringe, Humira Pen Psoriasis/Uveitis/Adol HidraSuppur Starter Pack, Humira Pen Crohns/Ulcer Colitis/Hidradenitis Suppurati StrPk

Adalimumab-atto injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and ankylosing spondylitis. It is used in children 4 years of age and older for juvenile idiopathic arthritis. Adalimumab-atto is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-atto may be used alone or in combination with medicines (eg, methotrexate).

Adalimumab-atto injection is also used to treat the symptoms of active Crohn’s disease in patients who have not been helped by other medicines (eg, infliximab). It is also used to treat moderate to severe ulcerative colitis in patients who have been treated with other medicines (eg, azathioprine, corticosteroids, or 6-mercaptopurine) that did not work well. Adalimumab-atto may also be used to treat moderate to severe chronic plaque psoriasis, which is a skin disease with red patches and white scales that don’t go away.

Adalimumab-atto is available only with your doctor’s prescription.

• Generic Name: empagliflozin / linagliptin
• Dosage Forms: n.a.
• Other Brand Names: Glyxambi

Empagliflozin and linagliptin is a combination medicine used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Empagliflozin and linagliptin is also used to lower the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have heart disease.

empagliflozin and linagliptin is not for treating type 1 diabetes.

Empagliflozin and linagliptin may also be used for purposes not listed in this medication guide.